Bain Capital
Bain Capital is a Boston-based multi-asset alternative investment firm that sources, funds, and manages investments across private equity, venture capital, credit, and public equity. Founded in 1984, it operates globally with specialized units focused on growth and buyout investments, life sciences, and impact-oriented opportunities. The firm backs companies across sectors including healthcare and life sciences, technology, software and data services, financial services, consumer, manufacturing, and industrials, spanning from early-stage ventures to growth equity and large-scale acquisitions. It emphasizes value creation through strategic support and partnerships, leveraging deep operating experience and a global network. Its life sciences arm targets pharmaceutical, biotechnology, medical device, and diagnostic companies; the Double Impact unit pursues market-rate returns alongside measurable social and environmental benefits; Bain Capital Ventures backs technology-enabled businesses from seed to growth across enterprise software, infrastructure, and services. The firm maintains offices in Boston and major markets worldwide, aiming to deliver competitive returns while supporting innovation and economic development.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Jennifer Davis
Partner, Private Equity, Consumer and Retail Vertical and Member of the North American Private Equity Team
Phillip Loughlin
Partner, Global Head of the Financial and Business Services Vertical and Member of the Consumer / Retail Vertical
Cara Nealon
Senior Vice President, Portfolio Group and Member of the North American Private Equity Team
Past deals in USA
Astronomer
Series D in 2025
Astronomer is a data engineering software company that builds a managed Apache Airflow platform. Founded in 2014 and based in Cincinnati, Astronomer offers Astro, a data orchestration platform powered by Apache Airflow that enables data teams to build, run, and observe data pipelines-as-code. The platform is designed to deploy, manage, and scale distributed Airflow workflows with features such as isolated resource allocation and controlled user access, supporting data engineers, data scientists, and data analysts in delivering trusted analytics. Astronomer's solutions help organizations increase data availability and visibility by making pipelines observable and governance-friendly across environments.
Lincoln Financial Group
Post in 2025
Founded in 1905, Lincoln Financial Group is a Fortune 500 company offering a diverse range of financial services and solutions, including investments, asset management, mutual funds, annuities, alternative investments, brokerage solutions, life insurance, retirement planning, and group benefits.
Sizzling Platter
Acquisition in 2025
Sizzling Platter, LLC is a food and beverage company that owns and manages a diverse portfolio of fast casual restaurants in the United States and internationally. Founded in 1963 and headquartered in Murray, Utah, the company offers a variety of menu items, including pizzas, donuts, coffee, burgers, steak, seafood, and salads, catering to a wide range of tastes. Sizzling Platter focuses on acquiring and supporting restaurant brands, providing them with resources for growth and financial success. The company also emphasizes social responsibility by donating food to those in need on designated days. Through its commitment to delivering exceptional dining experiences and supporting its brand partners, Sizzling Platter aims to establish itself as a leading franchise platform in the food service industry.
HealthEdge Software
Acquisition in 2025
HealthEdge provides a modern suite of products, HealthRules, built on patented technology. It enables healthcare payors to innovate, reduce costs, and improve outcomes by connecting everyone in the healthcare delivery cycle.
LightSource
Series A in 2025
LightSource develops a supply chain management platform to help professionals collaborate with their suppliers. It also allows collaborating with teammates on strategic sourcing projects, sending RFQs to suppliers and collecting quotes, and comparing bids using insights automatically extracted from the normal day-to-day work.
The company was founded in 2021 and is headquartered in San Francisco, California.
HeartFlow
Convertible Note in 2025
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.
Surf Internet
Private Equity Round in 2025
Surf Internet specializes in fiber optic and wireless broadband services for residential customers, businesses, educational institutions, and municipalities across Indiana, Illinois, and Michigan. It offers high-speed internet plans tailored to diverse usage needs, ensuring reliable connectivity for activities like streaming, gaming, and remote work. The company focuses on expanding its network infrastructure to improve service availability and performance, accompanied by dedicated customer support.
Solid Biosciences
Post in 2025
Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.
Abcuro
Series C in 2025
Abcuro develops immunotherapies targeting autoimmunity and cancer. Founded in 2015, the company uses bioinformatics and ex-vivo validation to uncover novel immune system targets.
SelectQuote
Post in 2025
SelectQuote Insurance Services, Inc. is an insurance company based in San Francisco, California, specializing in a diverse array of insurance products, including term life, auto, home, and Medicare insurance. Founded in 1985, SelectQuote aims to assist families by providing tailored insurance solutions that meet their specific needs and budget. Operating as a subsidiary of SelectQuote, Inc., the company utilizes a direct-to-consumer distribution model, allowing clients to compare rates from a wide range of highly rated insurance providers online. This approach ensures that consumers receive the best possible coverage at competitive prices. SelectQuote generates revenue through commissions earned by selling insurance products on behalf of its carrier partners and operates through four key segments: Senior, Healthcare Services, Life, and Auto & Home.
Cofactr
Series A in 2024
Cofactr specializes in end-to-end supply chain automation for critical industries such as aerospace, defense, medtech, and robotics. Established in New York in 2021, the company helps these sectors optimize procurement and logistics to deliver mission-critical hardware.
AutoComplete
Seed Round in 2024
AutoComplete, Inc. is an insurance-technology company headquartered in San Francisco, California. It focuses on integrating artificial intelligence at the point of sale, specifically targeting the substantial car insurance market valued at $311 billion. The company has developed an AI-driven platform that simplifies the process of obtaining auto protection, aiming to enhance the user experience by minimizing effort in securing automotive insurance. Through its innovative software, AutoComplete seeks to provide efficient solutions that redefine how consumers engage with auto insurance services.
Somacis
Acquisition in 2024
Somacis SpA specializes in the manufacturing and supply of printed circuit boards (PCBs), including rigid, flex, and rigid-flex types. The company is recognized for its expertise in high-density interconnect (HDI) and flex-rigid PCBs, offering solutions that accommodate up to 50 layers. Somacis provides a range of products such as buried components, metal core solutions, RF/microwave products, graphic overlays, touch screens, and custom membrane switches. Founded in 1972 and headquartered in Castelfidardo, Italy, Somacis operates additional production facilities in Manfredonia, Italy; Poway, California; and Guangdong, China. The company serves various industries, including telecommunications, aerospace, defense, industrial, medical, automotive, and information technology, catering to both time-sensitive and mass production needs.
Kestra Medical Technologies
Private Equity Round in 2024
Kestra Medical Technologies develops and commercializes wearable medical devices and digital health solutions for cardiovascular care. The company provides monitoring, data collection, and therapeutic intervention to protect at-risk patients, with real-time and retrospective analysis. Its Cardiac Recovery System platform integrates monitoring, therapy, digital health tools, and patient support into a single solution, anchored by the ASSURE wearable cardioverter defibrillator designed to prevent sudden cardiac death and aid cardiac recovery. Kestra aims to transform patient outcomes in cardiovascular disease through intuitive, connected technologies.
Momento
Series A in 2024
Momento was founded with the vision to enable developers to write reliable and powerful apps faster than ever thought possible. Momento removes the need to manage caches by providing a serverless caching solution that works at any scale, so developers can concentrate on doing what they love: developing better products and services, faster. Momento is a team of distributed systems and database experts. The company is headquartered out of Seattle, Washington with a team that is distributed worldwide.
Visit gomomento.com for more information—or see just how fast and simple it is to get going with Momento by starting for free at start.gomomento.com.
Envestnet
Acquisition in 2024
Envestnet, Inc. is a provider of technology-driven wealth management and financial wellness solutions, operating primarily in the United States and internationally. The company is structured into two segments: Envestnet Wealth Solutions and Envestnet Data & Analytics. It offers a range of services including an open architecture wealth management platform, data aggregation and reporting, digital advice capabilities, and software for trading, rebalancing, and client relationship management through its Tamarac platform. Additionally, Envestnet delivers goals-based financial planning solutions via MoneyGuide, and services for advisor-sold retirement plans through Envestnet Retirement Solutions. The company also provides research and consulting services to support financial advisors in developing investment strategies and optimizing portfolios. Envestnet primarily serves banks, wealth management firms, brokerages, and registered investment advisors, facilitating their business operations and enhancing client interactions. Founded in 1999, Envestnet is headquartered in Chicago, Illinois.
Archwest Capital
Acquisition in 2024
Archwest Capital is a provider of commercial real estate lending services that specializes in the multifamily and mixed-use sectors across the United States. The company offers a range of financing options, including bridge and permanent loans, to support various stages of property development, from ground-up construction to light and heavy rehabilitation, and through to stabilization. Archwest Capital distinguishes itself by providing flexible permanent financing alternatives that streamline the process, allowing clients to secure funding with speed and efficiency. By minimizing the need for multiple layers of credit approval, the company ensures transparency in every transaction, effectively addressing the specific housing needs of its clientele.
Cube Dev
Series B in 2024
Cube Dev provides an open-source analytical API platform that enables internal business intelligence and customer-facing analytics through a semantic layer. The semantic layer unifies business logic, centralizes governance and security, and optimizes query performance, while supporting integration with any data endpoint. Cube Cloud offers a managed infrastructure with query inspection and tracing, monitoring, and pre-aggregation management. The platform includes visualization-agnostic tools for building user interfaces and analytical APIs, and supports modern data stores to handle large data volumes with built-in security. Cube Dev serves organizations seeking scalable, governed analytics applications.
CereVasc
Series B in 2024
CereVasc, Inc. is a medical device company based in Auburndale, Massachusetts, specializing in the development of innovative, minimally invasive treatments for neurological diseases. The company has created the eShunt System, an endovascularly deliverable cerebrospinal fluid (CSF) shunt designed to replace traditional surgical methods for treating communicating hydrocephalus. This system aims to eliminate the need for invasive surgery, general anesthesia, and hospitalization, which are typically associated with the conventional use of ventriculo-peritoneal shunts. By providing a less invasive alternative, CereVasc seeks to improve patient outcomes and reduce the overall costs related to the surgical management of life-threatening neurological conditions. Established in 2014, CereVasc is focused on advancing healthcare solutions that enhance the treatment of various neurological brain disorders.
Sikich
Private Equity Round in 2024
Sikich is a Chicago-based professional services firm offering expert business advisory services tailored to middle-market businesses. The company provides a range of services including accounting, audit, tax, and consulting services.
Century Therapeutics
Post in 2024
Century Therapeutics is a biotechnology company developing allogeneic cell therapies derived from induced pluripotent stem cells to treat cancer and related diseases. Its platform enables engineering of iPSCs into NK and T cells with master cell banks of modified cells that can be expanded and differentiated into standardized, off-the-shelf therapies. The company combines CRISPR-mediated gene editing, proprietary chimeric antigen receptors, Allo-Evasion technology, and manufacturing capabilities to enable scalable production of homogeneous cell products for hematologic and solid tumors. While focused on oncology, its platform also targets autoimmune and inflammatory diseases with the goal of improving cell therapy performance and reducing host immune rejection.
Xilio Therapeutics
Post in 2024
Xilio Therapeutics is a clinical-stage biotechnology company focused on developing innovative immunotherapies to enhance the immune system's ability to combat cancer. The company specializes in tumor-selective immunotherapies, utilizing its proprietary technology to maximize the effectiveness of immuno-oncology treatments while minimizing side effects outside the tumor. Among its key products is XTX201, which aims to induce immune activity directly within tumors, demonstrating improved antitumor effects. Founded in 2015 and based in Waltham, Massachusetts, Xilio Therapeutics was previously known as Akrevia Therapeutics until its rebranding in March 2020. The company is dedicated to advancing a pipeline of novel immuno-oncology molecules, including tumor-activated cytokines and antibodies, with the goal of significantly improving patient outcomes in cancer treatment.
Areteia Therapeutics
Series A in 2024
Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.
Solid Biosciences
Post in 2024
Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.
MaintainX
Series C in 2023
MaintainX is a software-as-a-service platform that digitizes work orders and procedures for frontline and maintenance teams. The platform supports workflow digitization, collaboration, and analytics, along with environmental and training checklists, tooling and gauge reporting, auditing and inspection workflows, and quality control inspections, with capabilities to communicate and upload photos. It helps manufacturing facilities, restaurants, hotels, and other business groups streamline maintenance operations, manage asset information, and support regulatory compliance and audits. The solution emphasizes IoT-enabled features and real-time field insights to improve efficiency and reliability in maintenance, reliability, and operations. Founded in 2018 and headquartered in San Francisco, California, MaintainX provides a mobile-first platform designed to empower frontline workers with a modern digital workflow.
Gynesonics
Venture Round in 2023
Gynesonics, Inc. is a medical device company focused on developing innovative solutions for women's health, specifically addressing symptomatic uterine fibroids. Founded in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, Gynesonics offers the Sonata System, a minimally invasive treatment that utilizes sonography guidance for the transcervical ablation of fibroids. This incision-free approach provides a safe and effective alternative to traditional surgical methods such as hysterectomy or myomectomy, aiming to alleviate severe menstrual symptoms associated with fibroids. Gynesonics is dedicated to improving the quality of care for women by offering advanced technologies that enhance treatment options in gynecology.
Nimbus Therapeutics
Private Equity Round in 2023
Nimbus Therapeutics, LLC is a biotechnology company based in Cambridge, Massachusetts, focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. Founded in 2009, the company utilizes a computational technology-driven approach to advance a pipeline of novel small-molecule therapeutics. Nimbus Therapeutics specializes in designing allosteric inhibitors, notably targeting Acetyl-CoA Carboxylase for conditions such as non-alcoholic steatohepatitis and hepatocellular carcinoma. The company has established strategic partnerships with organizations like Charles River Laboratories and Celgene Corporation to enhance its drug development efforts. In March 2015, Nimbus Discovery rebranded itself as Nimbus Therapeutics to better reflect its transition into a clinical-stage enterprise.
Cofactr
Funding Round in 2023
Cofactr specializes in end-to-end supply chain automation for critical industries such as aerospace, defense, medtech, and robotics. Established in New York in 2021, the company helps these sectors optimize procurement and logistics to deliver mission-critical hardware.
Alkeus Pharmaceuticals
Series B in 2023
Alkeus Pharmaceuticals is a clinical-stage biopharmaceutical company based in Boston that specializes in developing treatments for serious ophthalmic conditions. The company's primary focus is on addressing untreatable diseases of the eye, with its lead drug candidate being an orally delivered compound aimed at treating Stargardt disease and age-related macular degeneration. Through its innovative approach, Alkeus aims to empower medical professionals to manage symptoms of irreversible vision loss at an earlier stage in affected patients.
HeartFlow
Series F in 2023
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.
MeTEOR Education
Acquisition in 2023
Founded in 1967, MeTEOR Education specializes in designing and equipping learning spaces for educational institutions across the United States. The company offers interior design services, furnishings, and solutions tailored to create high-impact learning experiences.
Surf Internet
Private Equity Round in 2023
Surf Internet specializes in fiber optic and wireless broadband services for residential customers, businesses, educational institutions, and municipalities across Indiana, Illinois, and Michigan. It offers high-speed internet plans tailored to diverse usage needs, ensuring reliable connectivity for activities like streaming, gaming, and remote work. The company focuses on expanding its network infrastructure to improve service availability and performance, accompanied by dedicated customer support.
Disc Medicine
Post in 2023
Disc Medicine is a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with severe hematologic disorders. Its pipeline includes therapies targeting erythropoietic porphyrias, Diamond-Blackfan Anemia, anemia of myelofibrosis and chronic kidney disease, as well as polycythemia vera.
Jnana Therapeutics
Series C in 2022
Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2016. It specializes in drug discovery, particularly focusing on solute carrier (SLC) transporters, which are vital for understanding various disease pathways. The company’s efforts are directed towards immunometabolism, lysosomal function, and mucosal defense, with applications in immuno-oncology, inflammatory disorders, and neurological diseases. Utilizing its proprietary RAPID platform, Jnana accelerates the identification of therapeutic targets and the development of small molecule therapies. By leveraging advanced chemoproteomics techniques, the company aims to enhance the efficiency of drug discovery and address significant unmet medical needs in patient care.
Momento
Seed Round in 2022
Momento was founded with the vision to enable developers to write reliable and powerful apps faster than ever thought possible. Momento removes the need to manage caches by providing a serverless caching solution that works at any scale, so developers can concentrate on doing what they love: developing better products and services, faster. Momento is a team of distributed systems and database experts. The company is headquartered out of Seattle, Washington with a team that is distributed worldwide.
Visit gomomento.com for more information—or see just how fast and simple it is to get going with Momento by starting for free at start.gomomento.com.
Oort
Seed Round in 2022
Oort is an identity threat detection and response platform focused on enhancing enterprise security. Recognizing that over 60% of security breaches involve the abuse of valid identity credentials, Oort positions identity as a critical aspect of cybersecurity. The company offers a Software as a Service (SaaS) platform that allows cybersecurity and IT professionals to efficiently manage their identity and access management (IAM) programs. With a quick deployment process and a focus on reducing identity vulnerabilities at scale, Oort provides organizations with enhanced visibility and control over their identity attack surface. It operates as a fully remote startup based in Boston, MA, and its innovative solutions help clients secure their digital supply chains. Oort is supported by prominent investors and aims to equip security teams with the tools needed to combat identity threats effectively.
Oort
Series A in 2022
Oort is an identity threat detection and response platform focused on enhancing enterprise security. Recognizing that over 60% of security breaches involve the abuse of valid identity credentials, Oort positions identity as a critical aspect of cybersecurity. The company offers a Software as a Service (SaaS) platform that allows cybersecurity and IT professionals to efficiently manage their identity and access management (IAM) programs. With a quick deployment process and a focus on reducing identity vulnerabilities at scale, Oort provides organizations with enhanced visibility and control over their identity attack surface. It operates as a fully remote startup based in Boston, MA, and its innovative solutions help clients secure their digital supply chains. Oort is supported by prominent investors and aims to equip security teams with the tools needed to combat identity threats effectively.
Solid Biosciences
Post in 2022
Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.
Nimbus Therapeutics
Venture Round in 2022
Nimbus Therapeutics, LLC is a biotechnology company based in Cambridge, Massachusetts, focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. Founded in 2009, the company utilizes a computational technology-driven approach to advance a pipeline of novel small-molecule therapeutics. Nimbus Therapeutics specializes in designing allosteric inhibitors, notably targeting Acetyl-CoA Carboxylase for conditions such as non-alcoholic steatohepatitis and hepatocellular carcinoma. The company has established strategic partnerships with organizations like Charles River Laboratories and Celgene Corporation to enhance its drug development efforts. In March 2015, Nimbus Discovery rebranded itself as Nimbus Therapeutics to better reflect its transition into a clinical-stage enterprise.
JenaValve Technology
Series C in 2022
JenaValve Technology, Inc. is a medical device company specializing in the design, development, and manufacturing of transcatheter aortic valve replacement (TAVR) systems for patients with severe aortic regurgitation and aortic stenosis. Founded in 2006 and headquartered in Irvine, California, with additional locations in Munich, Germany, and Leeds, United Kingdom, the company focuses on providing innovative solutions for high-risk patients who may not be suitable candidates for traditional surgical aortic valve replacement. The company's flagship product, the Trilogyâ„¢ Heart Valve System, received CE Mark approval in May 2021 and is notable for its dual-disease treatment capabilities. JenaValve's TAVR systems feature a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame, designed to engage with the native valve structures for optimal performance. The company has also received Breakthrough Device Designation from the U.S. Food and Drug Administration to facilitate the review of its pivotal trial for the Trilogy Heart Valve System in the United States.
Latchel
Series A in 2022
Founded in 2016, Latchel operates an online platform that streamlines maintenance coordination for property managers and landlords. Its platform enables tracking of maintenance requests, vendor selection, and mobile communication with tenants, aiming to increase net margins and renter satisfaction.
Areteia Therapeutics
Series A in 2022
Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.
X4 Pharmaceuticals
Post in 2022
X4 Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel oral small molecule therapeutics targeting chemokine receptor CXCR4. Its lead drug candidate, mavorixafor (X4P-001), is in Phase III trials for the treatment of WHIM syndrome and has shown promising results in other indications such as severe congenital neutropenia and clear cell renal cell carcinoma.
Grid.ai
Series B in 2022
Grid.ai, Inc. is a technology company founded in 2019 and based in New York, New York, that specializes in developing a platform for training artificial intelligence models using cloud-based graphics processing units (GPUs) and tensor processing units (TPUs). The platform provides several tools, including Grid Train, which facilitates research iteration and simplifies AI research, as well as Grid View, a web application for monitoring and managing infrastructure. Additionally, it offers Tensorboard for analyzing experiments. The company's solutions are designed to enhance the capabilities of machine learning engineers, data scientists, and AI researchers, allowing them to build advanced AI models and applications with minimal changes to existing code. Grid.ai emerged from the creators of the widely used PyTorch Lightning framework, further solidifying its expertise in high-performance AI research.
HYCU
Series B in 2022
HYCU is a leading provider of multi-cloud data protection as a service, specializing in data backup and recovery solutions for on-premises, cloud-native, and SaaS environments. The company's innovative R-Cloud platform delivers effective data protection, migration, disaster recovery, and ransomware protection, simplifying the process for thousands of organizations globally. By eliminating the complexities and costs associated with traditional data protection solutions, HYCU has established itself as a top choice in the SaaS data protection industry. The company is based in Boston, Massachusetts, and has achieved a notable Net Promoter Score reflecting high customer satisfaction. To date, HYCU has raised significant venture capital funding to support its growth and development in the competitive data management market.
Cuisine Solutions
Post in 2022
Cuisine Solutions is a United States-based company specializing in the production and marketing of sous-vide products and fully-cooked, frozen foods. Their diverse product range includes beef, lamb, pork, veal, poultry, seafood, and a variety of sauces and vegetarian options. The company caters to various channels and geographic regions, focusing on providing high-quality prepared foods that meet consumer demand for convenience and flavor.
JupiterOne
Series C in 2022
JupiterOne, Inc. is a cloud-based cybersecurity asset management and automation software company headquartered in Morrisville, North Carolina, with additional offices in Charlotte, Salt Lake City, and Seattle. Founded in 2018, JupiterOne provides organizations with tools designed to enhance visibility and compliance in their cloud infrastructure. Its software assists chief information security officers, security operations teams, and compliance officers by automating asset discovery, managing cloud posture, conducting risk analysis, and facilitating compliance reporting. The platform also enables vulnerability management, threat hunting, and incident response. Additionally, the JupiterOne Insights application allows users to create customized reporting dashboards and visualizations, aiding in the identification of security issues within code repositories and development processes. By offering continuous data aggregation and relationship modeling across all assets, JupiterOne simplifies cloud security, making it more accessible and effective for organizations.
Bubbles
Seed Round in 2022
Bubbles is a contextual collaboration tool that enables users to communicate asynchronously by tagging content directly on their screens. The platform facilitates discussions in-context through screen, video, and audio messages, allowing team members to capture, comment, and share information without the need for account creation or installation. Bubbles promotes organic growth and viral engagement rather than relying on paid advertising. It is actively engaged on various social media platforms, including Medium, Twitter, and Product Hunt, to enhance its visibility and user interaction.
Vertical Harvest Farms
Series A in 2022
Vertical Harvest Farms is a Wyoming-based agribusiness focused on hydroponic farming to provide fresh, locally grown produce year-round. The company aims to enhance the local economy by selling its products at competitive prices through various venues. It emphasizes inclusive employment opportunities for underserved populations, fostering community engagement and development. By utilizing vertical farming techniques in controlled environments, Vertical Harvest energizes local food systems and promotes healthier eating. Additionally, the company collaborates with communities to transform underutilized urban spaces into productive farms, supporting regional food networks while also enabling potential national expansion.
Cofactr
Seed Round in 2022
Cofactr specializes in end-to-end supply chain automation for critical industries such as aerospace, defense, medtech, and robotics. Established in New York in 2021, the company helps these sectors optimize procurement and logistics to deliver mission-critical hardware.
Fidel API
Series B in 2022
Fidel API is a financial infrastructure platform that allows developers to create programmable experiences during transaction events on payment cards. Established in 2018 and headquartered in London, with additional offices in Lisbon and New York, Fidel API provides tools that enhance interactions between merchants and consumers by facilitating real-time, event-driven engagements. The platform is designed to integrate seamlessly with major payment networks, such as Visa and Mastercard, to deliver detailed transaction data, including amount, location, date, and merchant. This capability supports improved marketing strategies and customer engagement through tailored loyalty and rewards programs, as well as streamlined processes for reimbursements and expense management. The company serves a diverse clientele, ranging from startups to large enterprises, and has established partnerships with prominent firms across various sectors.
Docker
Series C in 2022
Docker develops an open container platform for building, shipping, and running distributed applications. The platform enables developers and operations teams to package applications into portable containers that run consistently across laptops, on-premises data centers, and public cloud environments. It provides container runtime and packaging tools, development language support and tooling for building, scaling, deploying, and load balancing, and a cloud service for sharing applications and automating workflows. Founded in 2008 and based in San Francisco, the company aims to simplify application development and accelerate delivery from code to the cloud.
EarnUp
Series C in 2022
EarnUp Inc. is a fintech company based in San Francisco, California, that focuses on automating loan payments for consumers. Established in 2013, EarnUp's platform is designed to assist over 200 million Americans with debt by intelligently managing their financial obligations, including home mortgages, student loans, auto loans, and personal loans. The service allows users to set aside small amounts of money when financially feasible, which are then used to make loan payments on their behalf. By synchronizing micro-payments with users' income and lifestyle, EarnUp aims to streamline the debt repayment process and help individuals regain control over their finances, ultimately enabling them to pay off their debts more efficiently.
FreeWill
Series B in 2022
FreeWill Co. is a New York-based company that develops and operates an online estate planning platform. The service offers users access to legal forms and information, simplifying the process of estate planning and facilitating charitable donations. By providing free and user-friendly tools, FreeWill enables donors and fundraisers to make tax-advantaged gifts more easily, streamlining the process of making bequests and donations. The company's mission centers on addressing estate planning needs while promoting philanthropic efforts, ultimately making it simpler for individuals to contribute to charitable organizations.
Decodable
Series A in 2022
Decodable is a serverless data integration and engineering platform focused on streaming data, founded in 2021 by Eric Sammer and headquartered in San Francisco, California. The company offers a software solution that enables applications and data engineers to construct complex data pipelines efficiently. Its platform facilitates seamless connections to various existing messaging, storage, and database systems, allowing users to rapidly collect, process, and deliver data to both offline and online systems. Through its innovative approach, Decodable aims to simplify the management of streaming data, enhancing the capabilities of organizations in handling real-time data flows.
Vesta
Series A in 2022
Vesta Corporation is a provider of electronic payment solutions, specializing in client-branded services that enhance payment processing for merchants. The company offers a range of merchant solutions, including vSafe for Small to Midsize Businesses, which focuses on payment and fraud protection for smaller digital goods merchants, and vSafe for Enterprise, designed for comprehensive payments management and enterprise-level fraud prevention. Additionally, Vesta provides vGuaranteed, a payment solution tailored for online retailers, and DelayPay, a retail installment program that allows prepaid wireless customers to pay for services in installments. Founded in 1995 and headquartered in Lake Oswego, Oregon, Vesta operates globally, with centers in the United States, Ireland, China, and an office in Singapore. The company serves diverse industries, including e-commerce, telecommunications, and financial services, processing hundreds of millions of secure payments across various channels while prioritizing data security and fraud loss elimination.
soona
Series B in 2022
Soona is a virtual content studio founded in 2018 by Liz Giorgi and Hayley Anderson in Denver, Colorado. The company specializes in providing professional-level photo and video services tailored for e-commerce and marketing needs. Soona offers a diverse range of content solutions, including vlogs, brand shots, team photos, and green screen productions. By focusing on affordability and quality, Soona enables brands to create compelling visual content that effectively promotes their products and services.
Clockwise
Series C in 2022
Clockwise Inc. develops an AI-driven software solution for efficient time management. Its flagship product, Clockwise, is a smart calendar assistant that learns user preferences and optimizes schedules to balance focused work time and meetings, preventing burnout.
Zero Hash
Series D in 2022
Zero Hash is a B2B embedded infrastructure platform that enables businesses to integrate digital assets into their customer experience via API endpoints. It offers secure custody for both fiat and digital assets, handles regulatory compliance, and provides turnkey solutions for digital asset trading, crypto-backed rewards, and round-ups programs.
Cogsy
Seed Round in 2021
Cogsy is a technology company that simplifies website creation. It offers custom designs based on clients' branding, with sites scalable to handle high traffic and capable of integrating new functionalities via apps and widgets. The platform also provides tools for developers to build their own apps and widgets. Cogsy's core service is offered at $20 per month.
Sysdig
Series G in 2021
Sysdig develops real-time cloud security platforms that instantly detect and mitigate risks without hindering business operations. Its platform combines runtime insights, AI architecture, and integrations to uncover hidden attack paths, enabling security teams to prioritize critical threats effectively.
Hometap
Venture Round in 2021
Hometap, founded in 2018 and based in Boston, Massachusetts, is a fintech company that specializes in home equity investments. It allows homeowners to access funds immediately without taking on loans or selling their homes. Homeowners can use these funds for various purposes such as paying off debt or making renovations, all while avoiding added debt or monthly payments. Hometap provides this cash in exchange for a percentage of the future appreciation of the home's value.
OverIT
Acquisition in 2021
OverIT is a prominent provider of Field Service Management (FSM) software solutions, boasting over 20 years of experience in addressing complex field service challenges for enterprise businesses worldwide. The company serves over 300 clients, enhancing efficiency in linear asset management and facilitating the dispatch of more than 200,000 field workers daily. OverIT specializes in sectors such as energy and utilities, oil and gas, industrial manufacturing, and transportation, offering software that supports system upgrades, field service management, and hardware configurations. Recognized by leading advisory firms like IDC and Gartner, OverIT is acknowledged for its cutting-edge technology and ability to deliver scalable solutions that meet the critical operational needs of its clients.
Socure
Series E in 2021
Socure develops digital identity verification solutions using artificial intelligence and machine learning. Its platform authenticates identities in real-time from various online/offline sources, automating customer identification program (CIP), know your customer (KYC), and anti-money laundering (AML) compliance initiatives.
Cardurion Pharmaceuticals
Venture Round in 2021
Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.
Gluware
Private Equity Round in 2021
Gluware, Inc. is a developer of intelligent network automation and orchestration software that focuses on simplifying the management of multi-vendor and mission-critical networks. Founded in 2007 and headquartered in Sacramento, California, the company offers a range of products, including Gluware Control, a data-model driven platform that employs an intent-based orchestration engine. This platform features tools for configuration management, monitoring, and IT system workflow management, as well as solutions for managing network device software upgrades and ensuring configuration compliance. Gluware's offerings facilitate the automation of network lifecycle management, allowing organizations to deploy advanced network and security features more efficiently while minimizing manual intervention and operational costs. The company's innovative approach helps service providers and resellers deliver enterprise-grade cloud networking services to their clients. Gluware, previously known as Glue Networks, Inc., rebranded in August 2017.
Centivo
Venture Round in 2021
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
Ginkgo Bioworks
Post in 2021
Founded in 2008, Ginkgo Bioworks designs, engineers, and licenses organisms for various applications. It discovers molecules for flavors, sweeteners, cosmetics, crops, pharmaceuticals, and generates probiotic bacteria for health benefits. The company serves markets such as cultured ingredients, carbon mitigation, probiotics, and natural product discovery.
Wisetack
Series B in 2021
Wisetack operates a technology platform that enables in-person businesses to offer consumer-friendly financing options at the point of sale. Its platform integrates seamlessly with existing software platforms, allowing businesses to provide real-time lending solutions and enhance sales.
Cotopaxi
Series C in 2021
Cotopaxi is a direct-to-consumer outdoor gear and apparel company focused on social impact. Based in Salt Lake City, it links its products to humanitarian causes in developing countries, with each sale supporting education, clean water, or health projects. The company offers travel packs, activewear, outerwear, footwear, and water bottles made from responsibly sourced materials, and a portion of revenue is dedicated to charitable initiatives. The business emphasizes transparency about the impact of its donations.
Cube Dev
Series A in 2021
Cube Dev provides an open-source analytical API platform that enables internal business intelligence and customer-facing analytics through a semantic layer. The semantic layer unifies business logic, centralizes governance and security, and optimizes query performance, while supporting integration with any data endpoint. Cube Cloud offers a managed infrastructure with query inspection and tracing, monitoring, and pre-aggregation management. The platform includes visualization-agnostic tools for building user interfaces and analytical APIs, and supports modern data stores to handle large data volumes with built-in security. Cube Dev serves organizations seeking scalable, governed analytics applications.
Moveworks
Series C in 2021
Moveworks is a cloud-based AI platform for enterprises that automates IT support and related administrative tasks. The platform autonomously handles requests such as ordering hardware, provisioning software and account access, locating colleagues and conference rooms, checking ticket status, and obtaining software licenses, all through conversational interfaces. It integrates with enterprise chat tools like Slack to interact with users and trigger automated workflows. The solution uses a Reasoning Engine that combines public and proprietary large language models to interpret complex requests, execute multi-step processes, and adapt from past interactions. It surfaces information and automates tasks across multiple systems with an agentic AI assistant that enables conversational automation across business functions. Moveworks was founded in 2016 and is headquartered in Mountain View, California, with an additional office in Culver City, California.
Augtera Networks
Series A in 2021
Founded in 2016, Augtera Networks specializes in an AI-powered platform designed for complex network environments. It offers proactive operations, incident prevention, and seamless integration across physical, virtual, and cloud networks, serving hyper-scale cloud platforms, financial institutions, service providers, and enterprises.
Shipbob
Series E in 2021
Founded in 2014, Shipbob Inc. specializes in online shipping and fulfillment software for small e-commerce businesses. It aggregates services from major carriers like FedEx, UPS, and USPS, offering pickup, packaging, warehousing, batch fulfillment, and tracking solutions through its mobile app.
ConvenientMD
Private Equity Round in 2021
ConvenientMD LLC is an urgent care provider that specializes in treating non-life-threatening injuries and illnesses. Founded in 2011 and based in Portsmouth, New Hampshire, the company offers a range of services including treatment for sprains, strains, fractures, cuts, colds, bronchitis, and various infections. Additionally, ConvenientMD provides preventive care such as physicals, immunizations, and on-site prescriptions, along with X-ray and laboratory services. Patients can access care without an appointment, with centers open daily from 8 am to 8 pm, ensuring prompt service with minimal wait times. The company operates multiple locations across New Hampshire, Maine, and Massachusetts, emphasizing high-quality medical care delivered by a professional team using advanced medical equipment.
JupiterOne
Series B in 2021
JupiterOne, Inc. is a cloud-based cybersecurity asset management and automation software company headquartered in Morrisville, North Carolina, with additional offices in Charlotte, Salt Lake City, and Seattle. Founded in 2018, JupiterOne provides organizations with tools designed to enhance visibility and compliance in their cloud infrastructure. Its software assists chief information security officers, security operations teams, and compliance officers by automating asset discovery, managing cloud posture, conducting risk analysis, and facilitating compliance reporting. The platform also enables vulnerability management, threat hunting, and incident response. Additionally, the JupiterOne Insights application allows users to create customized reporting dashboards and visualizations, aiding in the identification of security issues within code repositories and development processes. By offering continuous data aggregation and relationship modeling across all assets, JupiterOne simplifies cloud security, making it more accessible and effective for organizations.
Sysdig
Series F in 2021
Sysdig develops real-time cloud security platforms that instantly detect and mitigate risks without hindering business operations. Its platform combines runtime insights, AI architecture, and integrations to uncover hidden attack paths, enabling security teams to prioritize critical threats effectively.
LvlUp Ventures
Funding Round in 2021
Founded in 2019, LvlUp Ventures is a global venture capital firm focused on accelerating and investing in top startups across various stages. With over 1500 team members worldwide, the firm reviews thousands of startup applications annually, creating numerous Fortune 500 programs and investment partnerships. LvlUp offers acceleration services for early-stage companies and direct investments for mature seed startups with promising traction.
Cerevel Therapeutics
Post in 2021
Cerevel Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neuroscience diseases. Founded in 2018 and headquartered in Cambridge, Massachusetts, the company is advancing a diverse pipeline that includes five clinical-stage investigational therapies and several preclinical compounds targeting conditions such as schizophrenia, epilepsy, Parkinson's disease, and substance use disorder. Key products under development include CVL-231, a positive allosteric modulator for schizophrenia; CVL-865, which is being tested for drug-resistant focal onset epilepsy and acute anxiety; and Tavapadon, a selective dopamine D1/D5 partial agonist for Parkinson's disease. Cerevel Therapeutics employs a unique approach that leverages expertise in neurocircuitry and receptor selectivity to address unmet medical needs in the field of neuroscience.
Crinetics Pharmaceuticals
Post in 2021
Crinetics Pharmaceuticals is a clinical-stage company focused on discovering, developing, and commercializing therapeutics targeting peptide hormone receptors for treating rare endocrine diseases and related cancers. Its lead product candidate, paltusotine, is an oral selective nonpeptide somatostatin receptor type 2 biased agonist in Phase I trials for acromegaly and neuroendocrine tumors.
Hand In Hand Soap
Funding Round in 2021
Hand In Hand Soap, founded in 2011 by Bill Glaab and Courtney Apple, is a personal care brand based in Wynnewood, Pennsylvania. The company specializes in a range of products including bar soap, liquid hand soap, hand sanitizer, body wash, sugar scrubs, and lotions. Committed to social responsibility, Hand In Hand operates a Give Back program, donating a bar of soap and access to clean water for every product sold, resulting in over 13 million bars of soap and significant contributions to water access for children in need. Additionally, the company prioritizes sustainability by producing palm oil-free products and actively educating consumers about the environmental and human rights issues associated with palm oil production.
Harry's
Series E in 2021
Founded in 2012, Harry's is a New York-based company that manufactures and sells high-quality shaving products. Its product range includes razors, shaving creams, grooming kits, and face care products, available both individually and through a subscription service.
HYCU
Series A in 2021
HYCU is a leading provider of multi-cloud data protection as a service, specializing in data backup and recovery solutions for on-premises, cloud-native, and SaaS environments. The company's innovative R-Cloud platform delivers effective data protection, migration, disaster recovery, and ransomware protection, simplifying the process for thousands of organizations globally. By eliminating the complexities and costs associated with traditional data protection solutions, HYCU has established itself as a top choice in the SaaS data protection industry. The company is based in Boston, Massachusetts, and has achieved a notable Net Promoter Score reflecting high customer satisfaction. To date, HYCU has raised significant venture capital funding to support its growth and development in the competitive data management market.
FourKites
Series D in 2021
FourKites provides a software platform for freight brokers and shippers to streamline operations through real-time shipment tracking across shippers, carriers, third-party logistics providers, and brokers. It offers an AI-driven control tower and a real-time visibility network that creates digital twins of the supply chain and uses AI-powered tools to automate resolution, enhance collaboration, and enable real-time execution. The platform provides predictive capabilities to track shipment locations, forecast arrivals, monitor load temperatures, and process actionable data from trucks, trailers, and cargo ships, helping businesses reduce costs, improve on-time performance, and strengthen customer relationships. Founded in 2013 and headquartered in Chicago, Illinois.
X4 Pharmaceuticals
Post in 2021
X4 Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel oral small molecule therapeutics targeting chemokine receptor CXCR4. Its lead drug candidate, mavorixafor (X4P-001), is in Phase III trials for the treatment of WHIM syndrome and has shown promising results in other indications such as severe congenital neutropenia and clear cell renal cell carcinoma.
Hi Marley
Series B in 2021
Hi Marley is a conversation platform for the insurance industry that combines intelligent messaging with human support to connect customers with insurers. The platform enables insurers to engage policyholders through messaging via its Marley web application, facilitating updates and responses to routine questions. It supports auto, home, and business lines and emphasizes real-time coaching, multilingual support, and automated workflows to enhance customer engagement and operational efficiency. Founded in 2017 and based in Boston, Massachusetts, the company targets insurers seeking to streamline communications and improve satisfaction through a shared messaging experience.
Clari
Series E in 2021
Clari Inc. is a revenue operations platform based in Sunnyvale, California, founded in 2012. The company utilizes automation and artificial intelligence to consolidate and analyze activity data from various business systems, such as CRM, email, calendar, and marketing automation. This integration provides sales professionals with improved visibility into their deals and relationships, enabling them to close deals more efficiently and reduce manual reporting efforts. Clari's platform offers features like Activity Analytics, which delivers predictive insights and real-time data analysis, allowing sales teams and managers to optimize their strategies, enhance coaching, and effectively allocate resources. By streamlining revenue operations, Clari assists B2B companies, including notable clients like Qualtrics and Adobe, in forecasting business performance, managing pipelines, and minimizing customer churn.
Decodable
Seed Round in 2021
Decodable is a serverless data integration and engineering platform focused on streaming data, founded in 2021 by Eric Sammer and headquartered in San Francisco, California. The company offers a software solution that enables applications and data engineers to construct complex data pipelines efficiently. Its platform facilitates seamless connections to various existing messaging, storage, and database systems, allowing users to rapidly collect, process, and deliver data to both offline and online systems. Through its innovative approach, Decodable aims to simplify the management of streaming data, enhancing the capabilities of organizations in handling real-time data flows.
Xilio Therapeutics
Series C in 2021
Xilio Therapeutics is a clinical-stage biotechnology company focused on developing innovative immunotherapies to enhance the immune system's ability to combat cancer. The company specializes in tumor-selective immunotherapies, utilizing its proprietary technology to maximize the effectiveness of immuno-oncology treatments while minimizing side effects outside the tumor. Among its key products is XTX201, which aims to induce immune activity directly within tumors, demonstrating improved antitumor effects. Founded in 2015 and based in Waltham, Massachusetts, Xilio Therapeutics was previously known as Akrevia Therapeutics until its rebranding in March 2020. The company is dedicated to advancing a pipeline of novel immuno-oncology molecules, including tumor-activated cytokines and antibodies, with the goal of significantly improving patient outcomes in cancer treatment.
EarnUp
Series B in 2021
EarnUp Inc. is a fintech company based in San Francisco, California, that focuses on automating loan payments for consumers. Established in 2013, EarnUp's platform is designed to assist over 200 million Americans with debt by intelligently managing their financial obligations, including home mortgages, student loans, auto loans, and personal loans. The service allows users to set aside small amounts of money when financially feasible, which are then used to make loan payments on their behalf. By synchronizing micro-payments with users' income and lifestyle, EarnUp aims to streamline the debt repayment process and help individuals regain control over their finances, ultimately enabling them to pay off their debts more efficiently.
Reprise
Series A in 2021
Reprise, Inc., established in 2019 and headquartered in Jackson, Wyoming, specializes in developing a demo creation platform. This platform empowers sales and marketing teams to create, edit, and deploy software product demos efficiently. By capturing screens of the product through a browser, altering text, data, and screen flow, and locking the replay as designed, Reprise enables businesses to produce customized demos, website-based product tours, and emailable product experiences directly from their existing production applications.
River 3 Renal
Series A in 2021
River 3 Renal is a developer of novel therapies designed to target orphan diseases in the renal space.
The company's technology has the potential to address the unmet need in several kidney diseases, by further improving the standard of care, enabling medical practitioners to treat patients in a better way.
River 3 Renal was established in 2020 in New York, USA.
Multi-Specialty HealthCare
Private Equity Round in 2021
Multi-Specialty HealthCare operates more than 30 patient care centers throughout the Baltimore-Washington metropolitan area and the Delmarva Peninsula. It employs a patient-centric, integrated model focused on delivering high-quality care to individuals injured in automobile and workplace accidents, regardless of their health insurance status. The company has a team of general practice and urgent care physicians, chiropractors, orthopedists, and other medical specialists who provide a full spectrum of treatment including physical rehabilitation, medical care, and other ancillary services.
TeachTown
Private Equity Round in 2021
TeachTown Inc. develops education solutions for students with autism spectrum disorder and other developmental and emotional/behavioral disorders. It offers TeachTown Basics, a computer-delivered and teacher-led ABA instruction program to improve vocabulary, listening, social-emotional development, independence, academics, and cognitive skills, and TeachTown Social Skills, an online social skills curriculum and assessment that uses character-based video modeling for elementary and middle school students. The company provides professional development for teachers, paraprofessionals, specialists, and administrators, and serves schools, children, and families through its online store.
EQRx
Series B in 2021
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.
Specto
Seed Round in 2021
Specto is a mobile application performance monitoring platform established in 2019 and headquartered in San Francisco, California. Designed by developers for developers, the platform simplifies the integration process, allowing users to collect vital performance metrics with minimal coding. Specto’s proprietary dashboard enables businesses to monitor their mobile applications effectively, providing insights into performance issues and their underlying causes. By combining data analysis with industry expertise, Specto equips clients with actionable insights to enhance their applications' performance and usability. The company is committed to offering hands-on support to ensure seamless implementation and optimal use of its technology.
Vesta
Seed Round in 2021
Vesta Corporation is a provider of electronic payment solutions, specializing in client-branded services that enhance payment processing for merchants. The company offers a range of merchant solutions, including vSafe for Small to Midsize Businesses, which focuses on payment and fraud protection for smaller digital goods merchants, and vSafe for Enterprise, designed for comprehensive payments management and enterprise-level fraud prevention. Additionally, Vesta provides vGuaranteed, a payment solution tailored for online retailers, and DelayPay, a retail installment program that allows prepaid wireless customers to pay for services in installments. Founded in 1995 and headquartered in Lake Oswego, Oregon, Vesta operates globally, with centers in the United States, Ireland, China, and an office in Singapore. The company serves diverse industries, including e-commerce, telecommunications, and financial services, processing hundreds of millions of secure payments across various channels while prioritizing data security and fraud loss elimination.
Solid Biosciences
Post in 2020
Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.
OpenFin
Venture Round in 2020
OpenFin provides runtime technology solutions for financial desktops. Its platform enables web applications to run outside the browser, generating real-time notifications, communicating with other applications, and meeting strict security standards. Serving financial services industries globally.
Centivo
Series B in 2020
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.